CME Group and S&P Global sell OSTTRA joint venture to KKR for $3.1B

CME GROUP INC.

Total enterprise value of $3.1 billion; proceeds split 50/50 between CME and S&P Global.
Transaction expected to close in second half of 2025, subject to regulatory approvals.
OSTTRA co-CEOs Guy Rowcliffe and John Stewart to remain in their current roles.
KKR to support OSTTRA with increased technology investments and an employee equity program.
OSTTRA, established in 2021, provides post-trade solutions for OTC markets including interest rates, FX, credit, and equities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.